United Therapeutics CFO James Edgemond sells USD 5.74 million common shares

United Therapeutics

United Therapeutics

UTHR

0.00
  • United Therapeutics CFO and Treasurer James Edgemond cut direct holdings to 18,876 shares in transactions dated May 11.
  • Disposed of 11,124 shares at prices mostly around USD 569.46 to USD 580.45 per share.
  • Transaction included exercise of 10,000 stock options at USD 135.42, leaving 12,500 stock options beneficially owned.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001636178-26-000017), on May 12, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.